SCHEMBL15580312

SCHEMBL15580312

COc1ccc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCn4c(nc(Cl)c4-c4ccccc4)C3)c12

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2B6 P20813 1/20 0.52
CYP2C19 P33261 1/20 0.52
KCNH2 Q12809 1/20 0.52
P2RX7 Q99572 5/20 0.33
PSEN1 P49768 2/20 0.31
PSEN2 P49810 2/20 0.31
APH1B Q8WW43 2/20 0.31
NCSTN Q92542 2/20 0.31
APH1A Q96BI3 2/20 0.31
PSENEN Q9NZ42 2/20 0.31
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30
TACR3 P29371 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10095028 0.90 CYP3A4 (0.67) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10094993 0.82 CYP3A4 (0.69) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12624834 0.82 CYP3A4 (0.68) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095030 0.82 CYP3A4 (0.68) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095029 0.81 CYP3A4 (0.67) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL21537945 0.80 CYP2C9 (0.78) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095033 0.80 CYP3A4 (0.65) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10094984 0.77 CYP3A4 (0.72) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10094979 0.77 CYP3A4 (0.72) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL10095004 0.75 CYP2C9 (0.66) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303876-B1 DIKETO AZOLOPIPERIDINES AND AZOLOPIPERAZINES AS ANTI-HIV AGENTS BRISTOL MYERS SQUIBB CO (US) 2014-03-19 EP disclosed